157 related articles for article (PubMed ID: 33226963)
21. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
22. Expression of p53 protein during the cell cycle measured by flow cytometry in human leukemia.
Danova M; Giordano M; Mazzini G; Riccardi A
Leuk Res; 1990; 14(5):417-22. PubMed ID: 2140591
[TBL] [Abstract][Full Text] [Related]
23. TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway.
Xing Y; Liu Y; Liu T; Meng Q; Lu H; Liu W; Hu J; Li C; Cao M; Yan S; Huang J; Wang T; Cai L
Cell Commun Signal; 2018 Jul; 16(1):43. PubMed ID: 30064446
[TBL] [Abstract][Full Text] [Related]
24. Promotion and maintenance of leukemia by ERG.
Tsuzuki S; Taguchi O; Seto M
Blood; 2011 Apr; 117(14):3858-68. PubMed ID: 21321361
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of Wild-Type p53-Expressing AML by the Novel Small Molecule HDM2 Inhibitor CGM097.
Weisberg E; Halilovic E; Cooke VG; Nonami A; Ren T; Sanda T; Simkin I; Yuan J; Antonakos B; Barys L; Ito M; Stone R; Galinsky I; Cowens K; Nelson E; Sattler M; Jeay S; Wuerthner JU; McDonough SM; Wiesmann M; Griffin JD
Mol Cancer Ther; 2015 Oct; 14(10):2249-59. PubMed ID: 26206331
[TBL] [Abstract][Full Text] [Related]
26. Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.
Wergeland L; Sjøholt G; Haaland I; Hovland R; Bruserud Ø; Gjertsen BT
Mol Cancer; 2007 May; 6():33. PubMed ID: 17498302
[TBL] [Abstract][Full Text] [Related]
27. Small-molecule MDM2 inhibitor LQFM030-induced apoptosis in p53-null K562 chronic myeloid leukemia cells.
de Oliveira Ribeiro H; Cortez AP; de Ávila RI; da Silva ACG; de Carvalho FS; Menegatti R; Lião LM; Valadares MC
Fundam Clin Pharmacol; 2020 Aug; 34(4):444-457. PubMed ID: 32011031
[TBL] [Abstract][Full Text] [Related]
28. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
29. The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR/ABL proteins.
You L; Liu H; Huang J; Xie W; Wei J; Ye X; Qian W
Oncotarget; 2017 Jan; 8(5):7777-7790. PubMed ID: 27999193
[TBL] [Abstract][Full Text] [Related]
30. Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.
Gustafsson B; Christenson B; Hjalmar V; Winiarski J
Med Pediatr Oncol; 2000 Feb; 34(2):117-24. PubMed ID: 10657873
[TBL] [Abstract][Full Text] [Related]
31. Antitumor immunity augments the therapeutic effects of p53 activation on acute myeloid leukemia.
Hayashi Y; Goyama S; Liu X; Tamura M; Asada S; Tanaka Y; Fukuyama T; Wunderlich M; O'Brien E; Mizukawa B; Yamazaki S; Matsumoto A; Yamasaki S; Shibata T; Matsuda K; Sashida G; Takizawa H; Kitamura T
Nat Commun; 2019 Oct; 10(1):4869. PubMed ID: 31653912
[TBL] [Abstract][Full Text] [Related]
32. Knockdown of IARS2 Inhibited Proliferation of Acute Myeloid Leukemia Cells by Regulating p53/p21/PCNA/eIF4E Pathway.
Li H; Tian Y; Li X; Wang B; Zhai D; Bai Y; Dong C; Chao X
Oncol Res; 2019 Jun; 27(6):673-680. PubMed ID: 30832756
[TBL] [Abstract][Full Text] [Related]
33. TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence.
Li K; Wang F; Cao WB; Lv XX; Hua F; Cui B; Yu JJ; Zhang XW; Shang S; Liu SS; Yu JM; Han MZ; Huang B; Zhang TT; Li X; Jiang JD; Hu ZW
Cancer Cell; 2017 May; 31(5):697-710.e7. PubMed ID: 28486108
[TBL] [Abstract][Full Text] [Related]
34. Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blasts.
Tazzari PL; Cappellini A; Ricci F; Evangelisti C; Papa V; Grafone T; Martinelli G; Conte R; Cocco L; McCubrey JA; Martelli AM
Leukemia; 2007 Mar; 21(3):427-38. PubMed ID: 17215852
[TBL] [Abstract][Full Text] [Related]
35. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
36. The promyelocytic leukemia protein protects p53 from Mdm2-mediated inhibition and degradation.
Louria-Hayon I; Grossman T; Sionov RV; Alsheich O; Pandolfi PP; Haupt Y
J Biol Chem; 2003 Aug; 278(35):33134-41. PubMed ID: 12810724
[TBL] [Abstract][Full Text] [Related]
37. Synergistic induction of p53 mediated apoptosis by valproic acid and nutlin-3 in acute myeloid leukemia.
McCormack E; Haaland I; Venås G; Forthun RB; Huseby S; Gausdal G; Knappskog S; Micklem DR; Lorens JB; Bruserud O; Gjertsen BT
Leukemia; 2012 May; 26(5):910-7. PubMed ID: 22064349
[TBL] [Abstract][Full Text] [Related]
38. p53 stabilization and functional impairment in the absence of genetic mutation or the alteration of the p14(ARF)-MDM2 loop in ex vivo and cultured adult T-cell leukemia/lymphoma cells.
Takemoto S; Trovato R; Cereseto A; Nicot C; Kislyakova T; Casareto L; Waldmann T; Torelli G; Franchini G
Blood; 2000 Jun; 95(12):3939-44. PubMed ID: 10845931
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.
Chim CS; Chan WW; Kwong YL
J Clin Pathol; 2008 Jul; 61(7):844-7. PubMed ID: 18587015
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
